Replies to post #72359 on Ariad Pharmaceuticals Inc fka ARIA

[biotech_researcher]

Quote:
"Investigators had informed the company about the frequency of CV events seen in EPIC, but “Ariad was not listening,” the second source said."

That is when the FDA Commissioner pull marketing rights for Iclusig off the market. Unquestionably the right thing to do with Ariad's cavalier attitude. If Ariad only approached the issue differently, the collapse in share price might have been lessened..